Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method. Testing was performed on 5% Mueller-Hinton agar using commercially available antimicrobial disks (BD) according to Clinical & Laboratory Standard Institute (CLSI) guidelines, M100-ed3037. The following disks were used for antimicrobial susceptibility testing: meropenem (10 µg), cefazolin (30 µg), cefepime (30 µg), ceftazidime (30 µg), ceftriaxone (30 µg), aztreonam (30 µg), ampicillin (10 µg), ampicillin-sulbactam (10/10 µg), amoxicillin-clavulanic acid (20/10 µg), piperacillin-tazobactam (100/10 µg), trimethoprim-sulfamethoxazole (1.25/23.75 µg), nitrofurantoin (300 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), amikacin (30 µg), gentamicin (10 µg), tobramycin (10 µg), and tetracycline (30 µg).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.